0.0300
0.0000
(0.00%)
At close: September 17 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-116,929
-116,929
-82,025
-77,514
-30,196
Investing Cash Flow
-103
-103
-414
-2,712
-22,214
Financing Cash Flow
124,470
124,470
2,560
47,804
192,341
End Cash Position
128,574
128,574
121,136
201,015
233,437
Capital Expenditure
-103
-103
-414
-2,712
-22,214
Issuance of Capital Stock
--
--
--
47,329
189,825
Free Cash Flow
-117,032
-117,032
-82,439
-80,226
-52,410
12/31/2021 - 1/8/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LIFE
ANVS Annovis Bio, Inc.
1.3000
+1.56%
AVXL Anavex Life Sciences Corp.
8.86
+3.75%
GLUE Monte Rosa Therapeutics, Inc.
4.2200
+1.69%
IKT Inhibikase Therapeutics, Inc.
2.0700
+11.29%
ABEO Abeona Therapeutics Inc.
4.6000
+10.05%
KTRA
SCPH scPharmaceuticals Inc.
2.3200
+15.14%
AXSM Axsome Therapeutics, Inc.
98.06
+2.52%
PIRS